Actively Recruiting
Comparing Local Radiotherapy Alone Versus Combined with Obinutuzumab for Early Stage Follicular Lymphoma in a Randomized Phase III Trial by Fondazione Italiana Linfomi
Led by Fondazione Italiana Linfomi - ETS · Updated on 2026-09-08
190
Participants Needed
49
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This trial studies patients with early stage Follicular Lymphoma who have not received prior treatment. It is a phase III, multicenter, randomized clinical trial comparing two treatments to evaluate which approach better controls the disease. The study is open label, meaning both patients and researchers know the assigned treatments. The purpose is to assess progression-free survival and other outcomes over several years. Participants are randomly assigned to one of two groups one receives involved-site radiotherapy alone at a standard dose of 24 Gy, and the other receives the same radiotherapy followed by eight doses of Obinutuzumab given intravenously over approximately nine months. The Obinutuzumab doses start with four weekly infusions followed by four infusions every three weeks. This comparison aims to evaluate the potential benefit of adding Obinutuzumab to radiotherapy. During the study, participants undergo PETCT scans for staging and assessments, blood tests including PCR for molecular markers, bone marrow biopsies, and other laboratory tests to monitor response and safety. Researchers measure outcomes such as progression-free survival over 33 months, complete and overall response rates, and event-free survival over up to 45 months. Safety and molecular studies including liquid biopsies and genetic analyses are also performed. Participants are followed for several years to monitor disease status and side effects.
CONDITIONS
Brief Title
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
Research Team
U
Uffici Studi FIL
U
Uffici Studi FIL
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here